UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of resistance to cisplatin and carboplatin

Critical reviews in oncology/hematology, 2007-07, Vol.63 (1), p.12-31

Stewart, David J

2007

Volltextzugriff (PDF)

Wnt Signaling Pathway in Non-Small Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2014-01, Vol.106 (1), p.djt356-djt356

STEWART, David J

2014

Volltextzugriff (PDF)

Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2925-2935

2010

Volltextzugriff (PDF)

Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4274-4280

2009

Volltextzugriff (PDF)

Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3345-3352

2012

Volltextzugriff (PDF)

Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4609-4615

2010

Volltextzugriff (PDF)

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

Critical reviews in oncology/hematology, 2010-09, Vol.75 (3), p.173-234

Stewart, David J

2010

Volltextzugriff (PDF)

Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas

Clinical cancer research, 2009-06, Vol.15 (11), p.3881-3888

2009

Volltextzugriff (PDF)

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.88-93

2014

Volltextzugriff (PDF)

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5407-5415

2008

Volltextzugriff (PDF)

Genome-Wide Association Study of Survival in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

JNCI : Journal of the National Cancer Institute, 2011-05, Vol.103 (10), p.817-825

2011

Volltextzugriff (PDF)

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4121-4128

2011

Volltextzugriff (PDF)

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy

Lung cancer (Amsterdam, Netherlands), 2011-01, Vol.71 (1), p.82-88

2011

Volltextzugriff (PDF)

Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer

Clinical cancer research, 2007-10, Vol.13 (19), p.5974-5981

2007

Volltextzugriff (PDF)

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1750-1758

2001

Volltextzugriff (PDF)

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer

Carcinogenesis (New York), 2011-07, Vol.32 (7), p.1050-1056

2011

Volltextzugriff (PDF)

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Clinical cancer research, 2010-07, Vol.16 (14), p.3743-3753

2010

Volltextzugriff (PDF)

EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma

Clinical cancer research, 2013-12, Vol.19 (23), p.6556-6565

2013

Volltextzugriff (PDF)

U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009

Clinical cancer research, 2014-07, Vol.20 (13), p.3364-3370

2014

Volltextzugriff (PDF)

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

Cancer, 2009-07, Vol.115 (13), p.2930-2938

2009

Volltextzugriff (PDF)

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

Clinical cancer research, 2013-12, Vol.19 (24), p.6967-6975

2013

Volltextzugriff (PDF)

Outcomes of Phase II Clinical Trials with Single-Agent Therapies in Advanced/Metastatic Non―Small Cell Lung Cancer Published between 2000 and 2009

Clinical cancer research, 2012-11, Vol.18 (22), p.6356-6363

2012

Volltextzugriff (PDF)

Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis

Cancer epidemiology, biomarkers & prevention, 2007-07, Vol.16 (7), p.1517-1522

2007

Volltextzugriff (PDF)

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.658-667

1999

Volltextzugriff (PDF)

1 – 25 von 1.275

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.209)
Mit Volltextzugriff
(1.083)

Publikationsform

Artikel
(1.265)
Tagungsberichte
(10)

Sprache

Englisch
(1.275)
Japanisch
(257)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.103)
Life Sciences & Biomedicine
(1.085)
Medical Sciences
(1.029)
Humans
(903)
Female
(625)
Male
(608)
Adult
(407)
Middle Aged
(407)
Fundamental And Applied Biological Sciences. Psychology
(306)
Aged
(295)
Pharmacology. Drug Treatments
(288)
Animals
(236)
Oncology
(205)
Adolescent
(145)
Treatment Outcome
(129)
General Aspects
(125)
Tumors
(125)
Antineoplastic Agents
(122)
Psychology. Psychoanalysis. Psychiatry
(110)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of resistance to cisplatin and carboplatin

Wnt Signaling Pathway in Non-Small Cell Lung Cancer

Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research

Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer

Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

An Analytical Framework for Delirium Research in Palliative Care Settings: Integrated Epidemiologic, Clinician-Researcher, and Knowledge User Perspectives

Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Genome-Wide Association Study of Survival in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy

Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma

U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

Outcomes of Phase II Clinical Trials with Single-Agent Therapies in Advanced/Metastatic Non―Small Cell Lung Cancer Published between 2000 and 2009

Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Aktive Filter

Suchergebnisse filtern